![](/images/graphics-bg.png)
Factors Associated with RANTES Concentration in Cardiovascular Disease Patients
Joint Authors
Dymicka-Piekarska, Violetta
Koper-Lenkiewicz, Olga M.
Kamińska, Joanna
Lisowska, Anna
Hirnle, Tomasz
Milewska, Anna Justyna
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-11, 11 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-07-18
Country of Publication
Egypt
No. of Pages
11
Main Subjects
Abstract EN
Objective.
The aim of the study was to establish, by means of linear regressions analysis, whether RANTES and CCL2 have a relationship with age, sex, heart rate, ejection fraction, white blood cells count, monocyte count, platelet count, mean platelet volume, hsCRP concentration, creatinine and eGFR value, applied treatments, and coronary risk factors in polish cardiovascular disease patients.
Methods.
Plasma chemokines concentrations were measured by ELISA method (R&D Systems Europe Ltd., Abingdon, England) in 115 cardiovascular disease patients (83 myocardial infarction/AMI and 32 stable angina/SA) and in the control group (N=25).
Results.
Univariate linear regression analysis found that (1) for men mean RANTES plasma level is 1.56 times higher as compared to women; (2) if patient’s age increases by 1 year, the mean RANTES concentration value increases by 1.4%; (3) if CCL2 concentration increases by 10 pg/mL, the mean RANTES concentration value increases by 3.3%; (4) if hsCRP concentration increases by 1 mg/L, the mean RANTES concentration value increases by 1.0%.
By means of multiple linear regression analysis we found that (1) for men the mean plasma RANTES concentration value increases 1.89 times as compared to women; (2) if CCL2 concentration increases by 10 pg/mL, the mean RANTES concentration value increases by 3.4%; (3) if MPV increases by 1 fL, the mean RANTES concentration value increases by 12%, if other model parameters are fixed.
For CCL2 we did not obtain statistically significant linear regression models.
Conclusion.
Due to high variability of obtained CCL2 concentrations, it seems that RANTES better reflects the presence of the atherosclerotic lesion than CCL2.
RANTES as a marker of atherosclerotic process may be an important therapeutic target, and the assessment of RANTES concentration should be interpreted depending on patient’s sex, age, platelet hyperactivity state, hsCRP, and CCL2 concentration.
American Psychological Association (APA)
Koper-Lenkiewicz, Olga M.& Kamińska, Joanna& Lisowska, Anna& Milewska, Anna Justyna& Hirnle, Tomasz& Dymicka-Piekarska, Violetta. 2019. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International،Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1124270
Modern Language Association (MLA)
Koper-Lenkiewicz, Olga M.…[et al.]. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International No. 2019 (2019), pp.1-11.
https://search.emarefa.net/detail/BIM-1124270
American Medical Association (AMA)
Koper-Lenkiewicz, Olga M.& Kamińska, Joanna& Lisowska, Anna& Milewska, Anna Justyna& Hirnle, Tomasz& Dymicka-Piekarska, Violetta. Factors Associated with RANTES Concentration in Cardiovascular Disease Patients. BioMed Research International. 2019. Vol. 2019, no. 2019, pp.1-11.
https://search.emarefa.net/detail/BIM-1124270
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1124270